Article info
PDFHead and Neck
Original research
Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy
- Correspondence to Dr Tomoyoshi Shigematsu, Department of Neurosurgery, Cerebrovascular center, Mount Sinai Health System, 1450 Madison Avenue, KCC 1-N, Box 1136, New York City, NY 10029, USA; s.tomoyoshi{at}mac.com
Citation
Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy
Publication history
- Received February 5, 2018
- Revised April 9, 2018
- Accepted April 10, 2018
- First published April 19, 2018.
Online issue publication
December 17, 2018
Article Versions
- Previous version (17 December 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.